Approval · Notice of Compliance 25954 · 2021
RUBY-FILL: Notice of Compliance 25954
Issued May 28, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25954
- Date
- May 28, 2021
- Company
- Jubilant Draximage Inc.Kirkland, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RUBY-FILL | Not yet assigned | — |
Medicinal ingredients
- RUBIDIUM CHLORIDE RB 82 3.7 GBQ per GEN